Trial of high flow nasal prong (HFNP) oxygen therapy for viral bronchiolitis in children's wards of south-west Sydney.
Not Applicable
- Conditions
- BronchiolitisRespiratory - Other respiratory disorders / diseases
- Registration Number
- ACTRN12611001016921
- Lead Sponsor
- Prof John Whitehall
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
*Male or female
*Clinical features typical of viral bronchiolitis
*Clinical features and SpO2 compatible with moderate to severe bronchiolitis
Exclusion Criteria
*Complications of bronchiolitis discovered before enrolment, including pneumothorax
*Pneumonia plus or minus bronchiolitis
*Rapid progression of illness preventing opportunity for informed consent of parents or guardians.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Decrease in intubation[At the end of the treatment, it will be determined how many cases needed intubation];Decrease in requirement for intensive care[At the end of the treatment, it will be determined how many cases needed transfer to intensive care unit]
- Secondary Outcome Measures
Name Time Method Reduction in transfer to children's hospital[At the end of the treatment, it will be evaluated how many cases could be managed well with HFNP and hence did not require transfer to a tertiary children's hospital.]